<DOC>
	<DOCNO>NCT00875407</DOCNO>
	<brief_summary>Context . Nuclear image plays central role management chromaffin-tissue derive tumor tumor cell exhibit peptide receptor proteins involved metabolism target specific radiopharmaceutics . Recently , expression dopamine-receptor D2 isoforms find endocrine tumor . Objective . The aim present study evaluate feasibility 123I-IBZM ( D2 agonist radiolabelled 123I ) patient PHEO and/or PGL . Diagnostic accuracy also compare traditional SPECT imaging procedure .</brief_summary>
	<brief_title>Feasibility 123I-IBZM Scintigraphy ( D2 Agonist ) Patients With Pheochromocytoma ( PHEO ) and/or Paraganglioma ( PGL ) : Study Pilot</brief_title>
	<detailed_description />
	<mesh_term>3-iodo-2-hydroxy-6-methoxy-N- ( ( 1-ethyl-2-pyrrolidinyl ) methyl ) benzamide</mesh_term>
	<criteria>Age + 18 year . The woman age procreate effective contraception negative pregnancy test ( absence effective contraception ) Having radiological functional imaging ( balance sheet ( assessment ) préIBZM ) consider adapt complete pathology . Having phéochromocytome paragangliome prove surgical operation view data balance sheet ( assessment ) préIBZM . With without allergy iodine . NEM2A 2B . Malignant Forms recover even partial , surgical gesture ( movement ) . Pregnant Women course feeding . Women age procreate without effective contraception , positive pregnancy test . Renal insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>